Back in 2004, Benitec sponsored a ddRNAi trial for HIV at the City of Hope. While we did not continue to pursue this strategy, the CoH did. In 2007, as a follow up to this work, the CoH started a ddRNAi treatment for Lymphoma suffering HIV patients.
This study enrolled ten patients and concludes next month. This means that we could see results from both Calimmune and the CoH presented at the conference in August.
- Forums
- ASX - By Stock
- BLT
- CoH HIV
CoH HIV
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online